<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="covidseq/PMC7131249/results/search/disease/results.xml">
  <result pre="10.1016/j.msard.2020.102097 102097 : Article Immunosuppression during the COVID-19 pandemic in" exact="neuromyelitis optica" post="spectrum disorders patients: A new challenge Carnero Contentti Edgar"/>
  <result pre="Organization, 2020). COVID-19 morbidity and mortality has been associated with" exact="respiratory failure" post="due to acute respiratory distress syndrome (ARDS) ( World"/>
  <result pre="and mortality has been associated with respiratory failure due to" exact="acute respiratory distress syndrome" post="(ARDS) ( World Health Organization, 2020; Chen et al.,"/>
  <result pre="related to elderly age and comorbidities such as heart diseases," exact="diabetes mellitus," post="cancer, smoking habit and lung disease such as asthma"/>
  <result pre="such as heart diseases, diabetes mellitus, cancer, smoking habit and" exact="lung disease" post="such as asthma or chronic obstructive pulmonary disease, among"/>
  <result pre="diabetes mellitus, cancer, smoking habit and lung disease such as" exact="asthma" post="or chronic obstructive pulmonary disease, among others ( World"/>
  <result pre="cancer, smoking habit and lung disease such as asthma or" exact="chronic obstructive pulmonary disease," post="among others ( World Health Organization, 2020). In this"/>
  <result pre="It was recently reported that increased interleukin (IL)âˆ’6 levels and" exact="pneumonia" post="were risk factors for mortality in a Chinese cohort"/>
  <result pre="an astrocytopathy often characterized by devastating neurological sequelae, including persistent" exact="paraplegia" post="and blindness ( Palace et al., 2019). Does NMOSD"/>
  <result pre="standard of care in hospitalized adult patients with severe COVID-19" exact="pneumonia" post="(ClinicalTrials.gov, Identifier: NCT04317092), and 2) eculizumab in confirmed COVID-19"/>
  <result pre="NCT04288713). Are any prophylactic or therapeutic measures recommended? Immunizations, particularly" exact="influenza" post="vaccine, pneumococcal vaccine and varicella zoster virus vaccine included"/>
  <result pre="and safety of tocilizumab in the treatment of new coronavirus" exact="pneumonia" post="(COVID-19) Lancet Respir 2020 http://www.chictr.org.cn/showprojen.aspx?proj=49409 Collongues N. Ayme-Dietrich E."/>
  <result pre="N. Ayme-Dietrich E. Monassier L. de Seze J Pharmacotherapy for" exact="neuromyelitis optica" post="spectrum disorders: current management and future options Drugs 79"/>
  <result pre="Kim H.J. N-MOmentum study investigators. Inebilizumab for the treatment of" exact="neuromyelitis optica" post="spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3"/>
  <result pre="Lin D.Y. Zeng D. Outcome prediction models in AQP4-IGG positive" exact="neuromyelitis optica" post="spectrum disorders Brain 142 2019 1310 1323 30938427 Pittock"/>
  <result pre="A. Fujita K.P. Armstrong R. Wingerchuk D.M Eculizumab in aquaporin-4-positive" exact="neuromyelitis optica" post="spectrum disorder N. Engl. J. Med. 381 7 2019"/>
  <result pre="Oeda T. Okada K. Safety and efficacy of rituximab in" exact="neuromyelitis optica" post="spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled"/>
  <result pre="Shi L. Wang Y. Pathological findings of COVID-19 associated with" exact="acute respiratory distress syndrome" post="Lancet Respir. Med. 2020 Feb 18pii: S2213-2600(20)30076-X[Epub ahead of"/>
  <result pre="Yamamura T. Kleiter I. Fujihara K. Trial of satralizumab in" exact="neuromyelitis optica" post="spectrum disorder N Engl J Med. 381 22 2019"/>
  <result pre="Zhang M. Qiu W. Tocilizumab versus azathioprine in highly relapsing" exact="neuromyelitis optica" post="spectrum disorders (TANGO): a head-to-head comparative study Multiple Scler."/>
 </snippets>
</snippetsTree>
